Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) — Financial Flexibility Index
Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) has a Financial Flexibility Index of 0.08x as of September 2025. Free cash flow of CN¥118.65 Million (operating CF CN¥79.81 Million minus capex CN¥38.83 Million) represents 0% of total liabilities (CN¥1.42 Billion). Check Shandong Jincheng Pharmaceutical and Che cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shandong Jincheng Pharmaceutical and Chemical Co Ltd Financial Flexibility Index (2008–2025)
Historical Financial Flexibility Index trend for Shandong Jincheng Pharmaceutical and Chemical Co Ltd across 18 annual periods. For the full cash flow conversion analysis, see how efficiently does Shandong Jincheng Pharmaceutical and Che generate cash.
Annual Financial Flexibility Index for Shandong Jincheng Pharmaceutical and Chemical Co Ltd (2008–2025)
Year-by-year free cash flow to debt coverage for Shandong Jincheng Pharmaceutical and Chemical Co Ltd. Explore cash flow to debt ratio of Shandong Jincheng Pharmaceutical and Che to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.29x | CN¥420.52 Million | CN¥319.64 Million | CN¥1.47 Billion | ▲ +15.7% |
| 2024 | 0.25x | CN¥439.20 Million | CN¥296.59 Million | CN¥1.77 Billion | ▼ -47.5% |
| 2023 | 0.47x | CN¥1.01 Billion | CN¥664.08 Million | CN¥2.14 Billion | ▲ +62.4% |
| 2022 | 0.29x | CN¥629.29 Million | CN¥255.63 Million | CN¥2.17 Billion | ▼ -34.4% |
| 2021 | 0.44x | CN¥813.33 Million | CN¥437.19 Million | CN¥1.84 Billion | ▼ -17.0% |
| 2020 | 0.53x | CN¥818.56 Million | CN¥546.13 Million | CN¥1.53 Billion | ▼ -14.3% |
| 2019 | 0.62x | CN¥939.63 Million | CN¥577.98 Million | CN¥1.51 Billion | ▲ +6.4% |
| 2018 | 0.59x | CN¥702.08 Million | CN¥352.20 Million | CN¥1.20 Billion | ▲ +63.8% |
| 2017 | 0.36x | CN¥345.63 Million | CN¥151.83 Million | CN¥966.24 Million | ▼ -32.8% |
| 2016 | 0.53x | CN¥400.38 Million | CN¥241.48 Million | CN¥752.68 Million | ▼ -0.8% |
| 2015 | 0.54x | CN¥367.77 Million | CN¥207.92 Million | CN¥685.95 Million | ▼ -5.4% |
| 2014 | 0.57x | CN¥379.02 Million | CN¥219.46 Million | CN¥668.61 Million | ▲ +23.6% |
| 2013 | 0.46x | CN¥254.10 Million | CN¥93.92 Million | CN¥554.11 Million | ▲ +15.7% |
| 2012 | 0.40x | CN¥195.81 Million | CN¥86.61 Million | CN¥494.26 Million | ▼ -12.0% |
| 2011 | 0.45x | CN¥197.69 Million | CN¥62.69 Million | CN¥439.36 Million | ▲ +7.7% |
| 2010 | 0.42x | CN¥243.46 Million | CN¥108.67 Million | CN¥582.62 Million | ▼ -13.3% |
| 2009 | 0.48x | CN¥198.21 Million | CN¥105.62 Million | CN¥411.04 Million | ▲ +137.7% |
| 2008 | 0.20x | CN¥83.10 Million | CN¥30.23 Million | CN¥409.67 Million | — |